LP4
Small Plaque Parapsoriasis (SPP) LP19.
Large Plaque Parapsoriasis (LPP) LP40.
Poikilodermia vasculare atrophicans (PVA) LP41.
Grading & Level of Importance: C
LP4
Small Plaque Parapsoriasis (SPP) LP19.
Large Plaque Parapsoriasis (LPP) LP40.
Poikilodermia vasculare atrophicans (PVA) LP41.
None
Rare. Second half of life (>50 years).
The clinical picture in some cases remains of psoriasis, without any etiopathogenetic relationship. However, there is a nosologic relationship to mycosis fungoides or other CTCL.
Unknown.
SPP: Small red-brown, indolent (no itch), slightly scaling macules (1-2 cm), following the splitskin lines.
LPP: large geographic irregular but sharply demarcated, slightly scaling macules or plaques; no itch.
PAV: Mottled slightly (pityriasiform) scaling erythematous patches.
SPP: predominantly trunk; skin split lines.
LPP: predominantly trunk and upper extremities.
PAV: trunk or total skin.
Small Plaque Parapsoriasis: usually no evolution into CTCL.
Large Plaque Parapsoriasis: potential precursor of CTCL (mycosis fungoides).
Poikiloderma atrophicans vasculare: potential precursor of CTCL (mycosis fungoides).
No special, biopsy.
Subtle eczematous changes of the epidermis with a few lymphocytes in the dermis and the epidermis. No band like infiltrate in the papilary dermis. No lymphocyte microabscesses in the epidermis.
Chronic over years or decades. Follow-up mandatory because of potential development of mycosis fungoides.
LPP and PAV may develop to CTCL, preferentially mycosis fungoides (years or decades).
Clinical picture, histopathology and course.
Atopic or seborrheic eczema, CTCL subtypes in particularmycosis fungoides, tinea corporis, pityriasis versicolor.
Prevention not possible. Topical therapy: photo-(helio-) or photochemotherapy. Glucocorticosteroid-cream temporarily.
Comments
Be the first one to leave a comment!